X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3875) 3875
Publication (223) 223
Book Chapter (59) 59
Book Review (59) 59
Conference Proceeding (4) 4
Magazine Article (3) 3
Dissertation (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2714) 2714
index medicus (1797) 1797
female (1648) 1648
male (1550) 1550
middle aged (1096) 1096
thromboembolic complications (1019) 1019
aged (942) 942
risk factors (899) 899
adult (884) 884
cardiac & cardiovascular systems (754) 754
thromboembolism (606) 606
thrombosis (595) 595
surgery (585) 585
thromboembolic events (533) 533
hematology (513) 513
treatment outcome (507) 507
anticoagulants - therapeutic use (501) 501
thromboembolic disease (468) 468
chronic thromboembolic pulmonary hypertension (460) 460
retrospective studies (455) 455
peripheral vascular disease (453) 453
stroke (442) 442
risk (425) 425
atrial fibrillation (422) 422
pulmonary embolism (411) 411
adolescent (367) 367
prevention (366) 366
anticoagulants (361) 361
aged, 80 and over (349) 349
medicine, general & internal (329) 329
risk-factors (326) 326
care and treatment (323) 323
venous thromboembolism (313) 313
diagnosis (309) 309
deep-vein thrombosis (306) 306
medicine & public health (304) 304
child (299) 299
anticoagulation (295) 295
warfarin (293) 293
incidence (292) 292
molecular-weight heparin (289) 289
venous thromboembolic disease (287) 287
thromboembolism - etiology (278) 278
pulmonary hypertension (274) 274
management (271) 271
therapy (262) 262
prospective studies (257) 257
respiratory system (245) 245
venous thrombosis (241) 241
clinical neurology (240) 240
chronic disease (239) 239
pulmonary embolism - complications (236) 236
complications (227) 227
abridged index medicus (223) 223
pulmonary-embolism (221) 221
mortality (218) 218
deep venous thrombosis (216) 216
analysis (211) 211
pediatrics (209) 209
thromboembolism - prevention & control (209) 209
follow-up studies (208) 208
child, preschool (205) 205
children (205) 205
cancer (204) 204
prevalence (201) 201
anticoagulants - adverse effects (200) 200
hypertension (200) 200
oncology (200) 200
time factors (200) 200
risk assessment (198) 198
disease (197) 197
atrial fibrillation - complications (193) 193
hypertension, pulmonary - etiology (191) 191
anticoagulants - administration & dosage (189) 189
young adult (189) 189
prognosis (186) 186
health aspects (184) 184
animals (183) 183
pregnancy (182) 182
venous thrombosis - etiology (179) 179
embolism (177) 177
cardiology (170) 170
thrombosis - etiology (167) 167
orthopedics (165) 165
thromboembolic risk (164) 164
prophylaxis (162) 162
radiology, nuclear medicine & medical imaging (161) 161
transesophageal echocardiography (159) 159
infant (158) 158
aspirin (155) 155
pulmonary embolism - etiology (151) 151
patients (148) 148
research (146) 146
antithrombotic therapy (145) 145
complications and side effects (145) 145
endarterectomy (144) 144
pulmonary embolism - diagnosis (143) 143
stroke - etiology (142) 142
echocardiography (136) 136
cardiovascular (135) 135
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3558) 3558
French (122) 122
German (111) 111
Russian (62) 62
Spanish (41) 41
Polish (32) 32
Japanese (24) 24
Portuguese (11) 11
Czech (6) 6
Korean (3) 3
Chinese (2) 2
Hungarian (2) 2
Turkish (2) 2
Georgian (1) 1
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American College of Cardiology, ISSN 0735-1097, 11/2017, Volume 70, Issue 20, pp. 2552 - 2565
In this second part of a 2-part review, we will review cancer or cancer therapy–associated systemic and pulmonary hypertension, QT prolongation, arrhythmias,... 
cancer therapy | thromboembolism | hypertension | cardiovascular complication | radiation therapy | CARDIAC & CARDIOVASCULAR SYSTEMS | PULMONARY ARTERIAL-HYPERTENSION | INDUCED QT PROLONGATION | MALIGNANT PERICARDIAL-EFFUSION | ATRIAL-FIBRILLATION | BREAST-CANCER | GROWTH-FACTOR RECEPTOR | HEART-DISEASE | VENOUS THROMBOEMBOLIC EVENTS | TYROSINE KINASE INHIBITOR | RENAL-CELL CANCER | Morbidity - trends | Cardiovascular Diseases - etiology | Neoplasms - therapy | Global Health | Cardiovascular Diseases - prevention & control | Humans | Disease Management | Cardiotoxicity | Combined Modality Therapy - adverse effects | Cardiovascular Diseases - diagnosis | Heart | Tyrosine | CT imaging | Care and treatment | Endothelial growth factors | Atrial fibrillation | Radiation | Development and progression | Diagnostic imaging | Antineoplastic agents | Coronary heart disease | Pulmonary hypertension | Best practices | Prevention | Antimitotic agents | Pulmonary embolism | Complications and side effects | Electrocardiogram | Atherosclerosis | Electrocardiography | Thromboembolism | Cardiology | Cancer | Hypertension | Conduction | Radiation effects | Complications | Lung cancer | Cardiovascular disease | Radiation therapy | Cancer therapies | Disease control | Patients | Pericardium | Fibrillation | Arteriosclerosis | Nitric oxide | Health risk assessment | Vascular endothelial growth factor | Radiation damage | Prolongation
Journal Article
Journal Article
European Heart Journal, ISSN 0195-668X, 01/2016, Volume 37, Issue 1, pp. 67 - 119
Document Reviewers: Victor Aboyans (CPG Review Coordinator) (France), Antonio Vaz Carneiro (CPG Review Coordinator) (Portugal), Stephan Achenbach (Germany),... 
Heart failure | Connective tissue disease | Lung disease | Left heart disease | Endothelin receptor antagonists | Congenital heart disease | Chronic thromboembolic | Pulmonary hypertension | Phosphodiesterase type 5 inhibitors | Guidelines | Respiratory failure | Prostacyclin analogues | Pulmonary arterial hypertension | CARDIAC & CARDIOVASCULAR SYSTEMS | BRAIN NATRIURETIC PEPTIDE | LONG-TERM SURVIVAL | PRESERVED EJECTION FRACTION | RANDOMIZED CONTROLLED-TRIAL | CALCIUM-CHANNEL BLOCKERS | RIGHT-VENTRICULAR DYSFUNCTION | ENDOTHELIN-RECEPTOR ANTAGONIST | PLACEBO-CONTROLLED TRIAL | EXTRACORPOREAL MEMBRANE-OXYGENATION | SEVERE PORTOPULMONARY HYPERTENSION | Risk Assessment - methods | Hypertension, Pulmonary - diagnosis | Hypertension, Portal - complications | Humans | Echocardiography - methods | Tomography, X-Ray Computed - methods | Genetic Counseling | Hypertension, Pulmonary - therapy | Hypertension, Portal - diagnosis | Drug Interactions | Cardiac Catheterization - methods | Electrocardiography | Magnetic Resonance Angiography - methods | Elective Surgical Procedures - methods | Child | Biomarkers - metabolism | Exercise Therapy - methods | Cross Infection - prevention & control | Risk Factors | Social Support | Connective Tissue Diseases - therapy | Antihypertensive Agents - therapeutic use | Hemangioma - diagnosis | Hemangioma - complications | Heart Defects, Congenital - complications | Hypertension, Portal - therapy | HIV Infections - complications | Heart Defects, Congenital - diagnosis | Travel Medicine - methods | Health Status | Hypertension, Pulmonary - etiology | Hemoptysis - etiology | Genetic Testing - methods | Thromboembolism - diagnosis | Hemangioma - therapy | Balloon Embolectomy - methods | Exercise Test - methods | HIV Infections - diagnosis | Multimodal Imaging - methods | Adult | Female | Terminal Care - methods | Pregnancy Complications, Cardiovascular - therapy | Ventricular Dysfunction, Right - therapy | Therapies, Investigational - methods | Respiratory Function Tests - methods | Connective Tissue Diseases - diagnosis | Treatment Outcome | Arrhythmias, Cardiac - etiology | Thromboembolism - therapy | Pregnancy | Algorithms | Thromboembolism - complications | HIV Infections - therapy | Ventricular Dysfunction, Right - complications | Combined Modality Therapy - methods | Heart Defects, Congenital - therapy | Lung Transplantation - methods | Referral and Consultation | Patient Compliance | Connective Tissue Diseases - complications
Journal Article
Seminars in Thrombosis and Hemostasis, ISSN 0094-6176, 06/2019, Volume 45, Issue 4, pp. 326 - 333
Abstract Arterial and venous thromboses are common in glioma patients, both in the perioperative period and throughout the course of the disease. High-grade... 
Review Article | thromboembolism | GLIOBLASTOMA-MULTIFORME | TRANSIENT ISCHEMIC ATTACK | BEVACIZUMAB THERAPY | TISSUE FACTOR EXPRESSION | INTRACRANIAL HEMORRHAGE | BRAIN-TUMORS | CANCER-PATIENTS | MOLECULAR-WEIGHT HEPARIN | glioma | THROMBOEMBOLIC EVENTS | PERIPHERAL VASCULAR DISEASE | deep venous thrombosis | pulmonary embolism | HEMATOLOGY | ischemic stroke
Journal Article
Blood, ISSN 0006-4971, 2009, Volume 114, Issue 14, pp. 2861 - 2868
Journal Article
Annals of Medicine, ISSN 0785-3890, 10/2018, Volume 50, Issue 7, pp. 549 - 555
Cardioversion is an essential component of rhythm control strategy for atrial fibrillation. The thromboembolic risk of cardioversion is well established and... 
thromboembolic complication | atrial fibrillation | Anticoagulation | cardioversion | RHYTHM CONTROL | TRANSESOPHAGEAL ECHOCARDIOGRAPHY | EDOXABAN | RISK | ELECTRICAL CARDIOVERSION | STROKE | MEDICINE, GENERAL & INTERNAL | THERAPY | WARFARIN | EMERGENCY-DEPARTMENT PATIENTS
Journal Article
Journal Article